Andean Precious Metals (CVE:APM – Free Report) had its target price cut by Desjardins from C$2.10 to C$2.00 in a research report sent to investors on Thursday morning,BayStreet.CA reports. They currently have a buy rating on the stock.
Andean Precious Metals Trading Up 7.5 %
APM stock opened at C$1.29 on Thursday. The firm has a market cap of C$135.47 million, a PE ratio of 2.55 and a beta of 1.22. Andean Precious Metals has a 1-year low of C$0.57 and a 1-year high of C$2.18. The stock has a 50-day moving average price of C$1.29 and a 200-day moving average price of C$1.36.
Insider Activity at Andean Precious Metals
In other news, Senior Officer Juan Carlos Sandoval Amare acquired 31,300 shares of the firm’s stock in a transaction that occurred on Friday, January 3rd. The stock was bought at an average price of C$1.21 per share, with a total value of C$37,860.48. 69.37% of the stock is owned by insiders.
About Andean Precious Metals
Aptorum Group Limited, a pharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of diseases with a focus on infectious diseases and cancers. Its pipeline enables the discovery of new therapeutics assets, such as systematic screening of existing approved drug molecules, and microbiome-based research platform for treatments of metabolic diseases.
Featured Articles
- Five stocks we like better than Andean Precious Metals
- What Does a Stock Split Mean?
- Everything About Amazon Stock Signals a Buy—Time to Load Up?
- Differences Between Momentum Investing and Long Term Investing
- 5 Reasons Five Below’s Stock Price Is Heading Higher This Year
- What is the Euro STOXX 50 Index?
- Broadcom: Why the Chip Stock Remains a Top Long-Term AI Play
Receive News & Ratings for Andean Precious Metals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Andean Precious Metals and related companies with MarketBeat.com's FREE daily email newsletter.
